###begin article-title 0
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD4</italic>
###xml 46 52 46 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD8 </italic>
###xml 56 63 56 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
Investigation of innate immunity genes CARD4, CARD8 and CARD15 as germline susceptibility factors for colorectal cancer
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 153 160 153 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 313 320 313 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 442 447 442 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD4</italic>
###xml 449 455 449 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD8 </italic>
###xml 459 466 459 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 515 522 <span type="species:ncbi:9606">patient</span>
Variation in genes involved in the innate immune response may play a role in the predisposition to colorectal cancer (CRC). Several polymorphisms of the CARD15 gene (caspase activating recruitment domain, member 15) have been reported to be associated with an increased susceptibility to Crohn disease. Since the CARD15 gene product and other CARD proteins function in innate immunity, we investigated the impact of germline variation at the CARD4, CARD8 and CARD15 loci on the risk for sporadic CRC, using a large patient sample from Northern Germany.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 444 449 442 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD </italic>
###xml 520 527 518 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 16 24 <span type="species:ncbi:9606">patients</span>
###xml 355 363 <span type="species:ncbi:9606">patients</span>
A total of 1044 patients who had been operated with sporadic colorectal carcinoma (median age at diagnosis: 59 years) were recruited and compared to 724 sex-matched, population-based control individuals (median age: 68 years). Genetic investigation was carried out following both a coding SNP and haplotype tagging approach. Subgroup analyses for N = 143 patients with early manifestation of CRC (</=50 age at diagnosis) were performed for all CARD loci and subgroup analyses for diverse age strata were carried out for CARD15 mutations R702W, G908R and L1007fs. In addition, all SNPs were tested for association with disease presentation and family history of CRC.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 459 466 457 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 556 559 554 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
###xml 578 586 576 584 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic </sub>
###xml 596 606 594 604 <sub xmlns:xlink="http://www.w3.org/1999/xlink">genotypic </sub>
###xml 618 626 616 624 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic </sub>
###xml 647 658 645 656 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ressessive </sub>
###xml 53 60 <span type="species:ncbi:9606">patient</span>
###xml 165 173 <span type="species:ncbi:9606">patients</span>
###xml 330 337 <span type="species:ncbi:9606">patient</span>
###xml 363 370 <span type="species:ncbi:9606">patient</span>
No significant differences were observed between the patient and control allelic or haplotypic spectra of the three genes under study for the total cohort (N = 1044 patients). None of the analysed SNPs was significantly associated with either tumour location or yielded significant association in the familial or non-familial CRC patient subgroups. However, in a patient subgroup (</=45 age at diagnosis) with early disease manifestation the mutant allele of CARD15 R702W was found to be significantly associated with disease susceptibility (9.7% in cases vs 4.6% in controls; Pallelic = 0.008, Pgenotypic = 0.0008, ORallelic = 2.22 (1.21-4.05) ORressessive = 21.9 (1.96-245.4).
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD4</italic>
###xml 46 52 46 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD8 </italic>
###xml 56 63 56 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 204 211 204 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 219 227 <span type="species:ncbi:9606">patients</span>
Variation in the innate immunity genes CARD4, CARD8 and CARD15 is unlikely to play a major role in the susceptibility to CRC in the German population. But, we report a significant disease contribution of CARD15 for CRC patients with very early disease manifestation, mainly driven by variant R702W.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 232 233 232 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 344 345 344 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 401 402 401 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 376 384 <span type="species:ncbi:9606">patients</span>
Colorectal cancer (CRC) occurs both as a part of recognized heritable syndromes and in the form of "sporadic" disease. However, epidemiological studies have also revealed familial clustering of CRC outside the recognized syndromes [1]. Estimates of the relative familial recurrence risk of nonsyndromic CRC range from 1.7 for unselected cases [2] to 6.2 for siblings of index patients aged <55 years [3]. As yet, the molecular basis of this familial clustering of "sporadic" CRC has not been fully explored.
###end p 11
###begin p 12
###xml 250 251 250 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 471 472 471 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 473 474 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 181 189 <span type="species:ncbi:9606">patients</span>
###xml 422 430 <span type="species:ncbi:9606">patients</span>
Epidemiological and functional evidence suggest that cancer may arise in the context of chronic inflammation. Inflammatory bowel disease (IBD) is a well established example in that patients with IBD have an increased risk for the development of CRC [4]. It is estimated that 1-2% of all CRC cases in general population are due to a complicated course of ulcerative colitis (UC) or Crohn disease (CD), and up to 15% of all patients with IBD develop CRC during their life [5,6]. Therefore, it appears sensible to hypothesize that genetic factors predisposing to, or involved in, the chronic inflammatory response in IBD also play an important role for the predisposition to CRC.
###end p 12
###begin p 13
###xml 19 26 19 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 219 220 219 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 221 222 221 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 307 308 307 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 318 325 318 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 664 666 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 685 687 685 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
As regards CD, the CARD15 (caspase recruitment domain family, member 15) gene mutations rs2066844 (R702W), rs2066845 (G908R) and rs2066847 (L1007fs) were originally shown to be associated with an increase disease risk [7,8], and this association has since been replicated in numerous Caucasian populations [9-11]. The CARD15 gene overlaps with the linkage-based IBD1 locus on chromosome 16q12. It exerts its biological function as part of a larger molecular network of genes involved in innate immune recognition and regulation [12]. There are two other genes in this CARD family that have been implicated in the etiology of IBD as well. These include CARD4/NOD1 [13] and CARD8/TUCAN [14], both of which also function as intracellular receptors of bacterial products, but with different ligand specificity.
###end p 13
###begin p 14
###xml 0 11 0 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD4/NOD1 </italic>
###xml 315 317 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 320 332 316 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD8/TUCAN </italic>
###xml 761 763 753 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
CARD4/NOD1 is located within a susceptibility locus for IBD on chromosome 7p14. CARD4 and is an additional PAMP receptor, that is linked to up apoptosis and activates NF-kappaB. The complex intronic indel polymorphism ND1+32656 (partially defined by rs6958571) has recently been reported to be associated with IBD [13]. CARD8/TUCAN (tumor-up-regulated CARD-containing antagonist of caspase nine) is expressed in gastrointestinal epithelium. There is evidence to suggest that CARD8 may be a negative regulator of NF-kappaB and also has a regulatory effect on apoptosis. The common variant rs2043211(c.30T>A) introduces a stop codon (Cys10Ter) at position 10 of the amino acid sequence. The common allele T was recently found to be associated with Crohn Disease [14].
###end p 14
###begin p 15
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 450 452 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 462 469 462 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 640 647 640 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 722 723 722 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 206 214 <span type="species:ncbi:9606">patients</span>
###xml 366 374 <span type="species:ncbi:9606">patients</span>
Recently, several studies implicated CARD15 in the susceptibility to CRC. Thus, Kurzawski et al. [15] observed an increased frequency in comparison to newborns of the 3020InsC mutation among 250 Polish CRC patients aged >50 years at the time of diagnosis resulting in an odds ratio of 2.2. Interestingly, no evidence for an association with CRC was found in younger patients. The 3020InsC association was confirmed in a subsequent study from Greece [16] and for CARD15 R702W in a study from New Zealand [17]. However, three subsequent studies from Finnland [18,19] and Hungary [20] failed to corroborate any of these findings. A summary of CARD15 allele frequencies observed in different CRC populations is given in Table 1.
###end p 15
###begin p 16
Summary of association analyses and overview of allele frequencies of CARD15 mutations stratified by age and population.
###end p 16
###begin p 17
* the initial investigation of 3020InsC utilised only 926 CRC cases ** genotype frequencies of carriership of mutant allele
###end p 17
###begin p 18
###xml 210 215 210 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD4</italic>
###xml 217 223 217 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD8 </italic>
###xml 227 234 227 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
In view of these controversial results, and in order to obtain a more complete assessment of the impact of variation in the innate immunity genes on CRC susceptibility, we investigated multiple variants of the CARD4, CARD8 and CARD15 genes in a large case-control sample from Northern Germany, following both a haplotype tagging and a coding SNP approach.
###end p 18
###begin title 19
Methods
###end title 19
###begin title 20
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and phenotypes
###end title 20
###begin p 21
###xml 815 817 815 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1428 1430 1428 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1698 1699 1698 1699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 2251 2253 2251 2253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 209 217 <span type="species:ncbi:9606">Patients</span>
###xml 244 252 <span type="species:ncbi:9606">patients</span>
###xml 647 655 <span type="species:ncbi:9606">Patients</span>
###xml 946 953 <span type="species:ncbi:9606">patient</span>
###xml 1143 1155 <span type="species:ncbi:9606">participants</span>
###xml 1302 1310 <span type="species:ncbi:9606">Patients</span>
###xml 1441 1449 <span type="species:ncbi:9606">patients</span>
###xml 1548 1560 <span type="species:ncbi:9606">participants</span>
###xml 1620 1628 <span type="species:ncbi:9606">patients</span>
###xml 1702 1710 <span type="species:ncbi:9606">Patients</span>
###xml 1799 1807 <span type="species:ncbi:9606">Patients</span>
Patients with histologically confirmed colorectal carcinoma (CRC) were identified through the regional cancer registry of Schleswig-Holstein or through the records of surgical departments in Northern Germany. Patients logged in the registry or patients operated with sporadic CRC between 2002 and 2005 at hospitals in Kiel, Eckernforde, Rendsburg, Schleswig, Flensburg, Husum, Heide, Niebull, Neumunster, Itzehoe, Rotenburg, Stade, Reinbek, Bad Oldesloh, Detmold, Neustadt, Hamburg-Harburg, Hamburg-Altona, Hamburg-Eilbek, Hamburg-Bergedorf, Hamburg-Barmbek, Bremen and Luneburg were contacted by mail and invited for participation in this study. Patients who did not respond were sent one written reminder. Individuals who agreed to participate were contacted through the recruitment office of the POPGEN biobank [21]. They were interviewed by mail questionnaire and a venous EDTA blood sample was obtained either at the POPGEN office or by the patient's general practitioner. All study protocols were approved by the institutional ethics committees and the local data protection officer. Written informed consent was obtained from all study participants. For both cases and controls, the study was restricted to probands of German ancestry, i. e. only individuals whose parents were born in Germany. Patients and controls fulfilling either of the clinical Amsterdam or Bethesda criteria for HNPCC were excluded for the study [22], as were patients with a history of inflammatory bowel disease (IBD). The first consecutive 522 male and 522 female participants were included in the study, yielding a sample size of 1044 patients. The median age at diagnosis was 59 years (range: 18-92 years; Table 2). Patients with FAP (as were all other known monogenic forms of CRC) were excluded from the study. Patients having at least 1 first-degree relative diagnosed with CRC were defined as familial cases, whereas non-familial cases had no first-degree relatives with CRC. Healthy control individuals (N = 724, including 362 males) with a median age at time of recruitment of 68 years (range: 48-81 years) were obtained from the population-derived pool of controls individuals in the POPGEN project, identified on the basis of the local population registry [21]. Control individuals with a history of malignant disease or IBD were excluded from the study. Controls were sex- and age-matched to the case sample, with a median age of 10 (+/- 1) years above the cases' age at diagnosis.
###end p 21
###begin p 22
Overview and clinicopathologic characteristics of the cohorts and subgroups used in the present study.
###end p 22
###begin p 23
###xml 113 120 <span type="species:ncbi:9606">patient</span>
Subcohorts 1-4 were not significantly different in respect to tumor location and family history to the total CRC patient cohort.
###end p 23
###begin title 24
Genotyping
###end title 24
###begin p 25
###xml 1154 1156 1147 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
DNA from all samples was prepared using the FlexiGene chemistry (Qiagen, Hilden, Germany) according to the manufactures protocols. DNA samples were evaluated by gel electrophoresis and adjusted to 20-30 ng/mul DNA content using the Picogreen fluorescent dye (Molecular Probes - Invitrogen, Carlsbad, Ca, USA). One microliter of genomic DNA was amplified with the GenomiPhi (Amersham, Uppsala, Sweden) whole genome amplication kit and fragmented at 99degreesC for three minutes. One hundred nanograms of DNA were dryed overnight in TwinTec hardshell 384 well plates (Eppendorf, Hamburg, Germany) at room temperature. Genotyping was performed for these plates using the SNPlex chemistry (Applied Biosystems, Foster City, USA) on an automated platform with TECAN Freedom EVO and 384 well TEMO liquid handling robots (TECAN, Mannedorf, Switzerland). Genotypes were reviewed manually using the Genemapper 4.0 (Applied Biosystems) software. None of the variants showed a significant departure from Hardy-Weinberg equilibrium (p > 0.1), indicating robust genotyping in this experiment. All process data were logged and administered with a database-driven LIMS [23].
###end p 25
###begin p 26
###xml 721 723 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
Genotypes of nonsynonymous polymorphism R702W (rs2066844) and the complex intronic indel polymorphism ND1+32656 (PCR forward primer GTCCTTCTGGTGTACTGATGT ATGAAA, PCR reverse primer, Taqman probe VIC (T-allele): CGCCCCCCACACA, Taqman probe FAM [GG-allele): CCCCCCCCCACAC) were determined using the TaqMan (Applied Biosystems) system. Reactions were completed and read in a 7900 HT TaqMan sequence detector system (Applied Biosystems). The amplification reaction was carried out with the TaqMan universal master mix. Thermal cycling conditions consisted of 1 cycle for 10 minutes at 95degreesC, 45 cycles for 15 seconds at 95degreesC, and 45 cycles for 1 minute at 60degreesC. Primers and probes have been reported before [24].
###end p 26
###begin title 27
SNP selection and data analysis
###end title 27
###begin p 28
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 406 407 404 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 409 410 407 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 415 416 413 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
For all genes, single nucleotide polymorphism (SNPs) were retrieved from HAPMAP  by the automated selection, from the CEU dataset, of haplotype tagging SNPs for Causcasians (setting: Mendel errors: 0, minor allele frequency >0.05, HWE cut-off p > 0.01) [25]. In addition, coding SNPs reported in dbSNP or in the literature were included if they had a a minor allel frequency >/=0.01 in Caucasians. Figures 1, 2 and 3 show the distribution of markers across genes and the regional haplotype structures as generated by HAPLOVIEW.
###end p 28
###begin p 29
###xml 0 71 0 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Overview of the physical and genetic structure of the CARD4 gene region</bold>
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
Overview of the physical and genetic structure of the CARD4 gene region. The gene is annotated on the genomic minus strand. The physical position of the investigated SNPs and a schematic illustration of the gene structure are shown in the top panel. The coordinates refer to genome assembly build 35. The lower panel gives an overview of the linkage disequilibrium structure of the locus [D'] as generated by Haploview [29]. The LD plots have been generated from the HAPMAP data.
###end p 29
###begin p 30
###xml 0 76 0 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Overview of the physical and genetic structure of the gene CARD8 gene region</bold>
Overview of the physical and genetic structure of the gene CARD8 gene region. The gene is annotated on the genomic minus strand. For details, see legend to Figure 1.
###end p 30
###begin p 31
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Overview of the physical and genetic structure of the gene CARD15 gene region</bold>
Overview of the physical and genetic structure of the gene CARD15 gene region: The gene is annotated on the genomic plus strand. For details, see legend to Figure 1.
###end p 31
###begin p 32
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 789 791 789 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 970 976 <span type="species:ncbi:76720">fisher</span>
The study was of case-control design. In order to improve power - i. e. to detect association to variants on the haplotypes, that are not directly tagged by one of the SNPs in the experiments - a sliding window haplotype analysis using window sizes of two to five markers was performed. Haplotype analysis was performed using COCAPHASE through the UNPHASED suite of programs [26]. COCAPHASE performs likelihood ratio tests under a log-linear model of the probability that a haplotype belongs to the case rather than to the control group. The expectation maximization (EM) algorithm is utilized to resolve uncertain haplotypes and provides maximum-likelihood estimates of frequencies. One single overall test statistic per sliding window (HAP2-5) is reported as a global significance value P for each haplotype tested. Nominal p values will be reported fo all tests. Single-point genotype- and allele-based tests of association were performed using a chi-squared test or fisher exact test.
###end p 32
###begin title 33
Results
###end title 33
###begin p 34
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 392 393 392 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
A systematic power analysis was performed for the 1044 cases and 724 controls available for study, adopting various allelic odds ratio between 1 and 2, a nominal significance level of 0.05, and minor allele frequencies of 0.1, 0.2, 0.3, 0.4 and 0.5 for a potential susceptibility mutation, respectively [27]. The power to detect odds ratios >1.5 was found to be >80% under all models (Figure 4). For frequent susceptibility factors, even odds ratios >1.3 would be detectable with the same power.
###end p 34
###begin p 35
###xml 0 54 0 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Power analysis of the sample used in the present study</bold>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
Power analysis of the sample used in the present study. The power of an allelic test is plotted as a function of the underlying odds ration of the tested genetic variant. Calculations were performed for a nominal significance level of 0.05 in a two-sided test. The different colors denote the frequency of the minor allele of the respective variant. Clearly, power increased for frequent variants and higher underlying odds. It is evident, that odds ratios above 1.6 should be detectable with a power greater 80% for all allele frequencies. The graph was generated using PS-power [27] and shows the power as a function of the odds ratio (x-axis).
###end p 35
###begin p 36
###xml 210 216 208 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD4 </italic>
###xml 237 242 235 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD8</italic>
###xml 262 269 260 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 428 430 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 458 460 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 626 633 624 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 1017 1024 1015 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 657 665 <span type="species:ncbi:9606">patients</span>
All tagging SNPs (see Methods section) from the three candidate genes and all validated nonsynonymous SNPs with a minor allele frequency >/=1% in Caucasians were included in the genotyping. Sixteen SNPs in the CARD4 gene, 13 SNPs in the CARD8, and 8 SNPs in the CARD15 gene were selected. These markers provided a good coverage of the respective genes and tagged all major haplotype blocks as determined by the tagging routine [28] implemented in HAPLOVIEW [29]. The disease association analyses were performed in single-tier fashion, using all cases and controls. Because earlier reports have indicated age-stratification of CARD15 association and younger patients in general may have a stronger genetic component to their disease, a separate analysis including only cases with an age of onset below 50 (median age of onset 45) compared to a sexmatched control population was performed, too. In addition, a further subgroup analysis for cases with an age of onset below 45 (median age of onset 41) was performed for CARD15 risk variants, too.
###end p 36
###begin title 37
CARD4
###end title 37
###begin p 38
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD4</italic>
###xml 54 55 54 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 246 247 246 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 640 642 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 788 790 788 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 957 959 957 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 974 982 <span type="species:ncbi:9606">patients</span>
###xml 1061 1068 <span type="species:ncbi:9606">patient</span>
For CARD4, some 16 SNP markers were genotyped. Figure 1 provides an overview of the linkage disequilibrium pattern generated from Hapmap Caucasian samples and the location of the tag SNPs in the gene. Association findings are summarised in Table 3. Nominal p-values for allelic association tests in the total cohort ranged from 0.10 to 0.92; sliding window haplotype analyses of two to five markers yielded p values between 0.08 and 0.99, respectively. The complex intronic indel polymorphism ND1+32656 yielded a p-value of 0.13 for the total cohort. ND1+32656 is part of a conserved haplotype also defined by SNPs rs2907748 and rs2907749 [30]. Both SNPs rs2907748 and rs2907749 (31 bp downstream to rs6958571) were also included in our experiments for ease and robustness of genotyping [30] and yielded similar p-values as ND1+32656. The non-synonymous coding SNP E266K, which was reported to be associated with disease susceptibility for Crohn's disease [31] in Hungarian patients, yielded a p-value of 0.36 for the total cohort. In the analysis of the total patient sample, none of the single point or haplotype analyses revealed any significant association with CRC risk.
###end p 38
###begin p 39
###xml 59 65 59 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD4 </italic>
Results of the association analyses of tagging SNPs in the CARD4 gene.
###end p 39
###begin p 40
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 138 140 138 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink"># </sup>
###xml 324 331 324 331 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic</sub>
###xml 348 353 348 353 <sub xmlns:xlink="http://www.w3.org/1999/xlink">HAP2 </sub>
###xml 357 362 357 362 <sub xmlns:xlink="http://www.w3.org/1999/xlink">HAP5 </sub>
###xml 438 443 438 443 <sub xmlns:xlink="http://www.w3.org/1999/xlink">HAP3 </sub>
a P value were not significant after Bonferroni correction for multiple testing, *no odds ratio calculated owing to low allele frequency, # p value reported for the first marker in the haplotype. The minor allele frequencies (MAF) for cases and controls are reported. P values and odds ratios are reported for the allelic (pallelic) test. Columns PHAP2 to PHAP5 refer to a sliding window haplotype analysis using COCAPHASE. For example, PHAP3 (0.252) for rs5743369 reports the global significance value for the window 3 haplotype spanning rs5743369- rs10267377- rs2907748.
###end p 40
###begin p 41
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 235 243 233 241 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic </sub>
###xml 252 262 250 260 <sub xmlns:xlink="http://www.w3.org/1999/xlink">genotypic </sub>
###xml 273 281 271 279 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic </sub>
###xml 418 426 416 424 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic </sub>
###xml 437 445 435 443 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic </sub>
###xml 564 566 562 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 665 673 663 671 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic </sub>
###xml 682 692 680 690 <sub xmlns:xlink="http://www.w3.org/1999/xlink">genotypic </sub>
###xml 703 711 701 709 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic </sub>
###xml 25 33 <span type="species:ncbi:9606">patients</span>
###xml 183 191 <span type="species:ncbi:9606">patients</span>
###xml 385 393 <span type="species:ncbi:9606">patients</span>
###xml 630 638 <span type="species:ncbi:9606">patients</span>
The subgroup analysis of patients younger than 50 years at onset of disease for ND1+32656 yielded an allelic p-value of 0.06 (Table 2). The subgroup analysis of the most youngest CRC patients (N = 72; </=45 age at diagnosis) yielded (Pallelic = 0.06, Pgenotypic = 0.025, ORallelic = 1.29 (0.79-2.11) and did not improve the results. For E266K a significant association was observed in patients younger than 50 years (Pallelic = 0.004, ORallelic = 0.62 (0.45-0.86). A similarly p-value of 0.003 was yielded for the intronic tag SNP rs2075819 that is in strong LD (r2 = 0.9) to E266K. The subgroup analysis of the most youngest CRC patients (<45) for E266K yielded (Pallelic = 0.03, Pgenotypic = 0.014, ORallelic = 0.48 (0.28-0.82)). However, both E266K and rs2075819 only have borderline significance in respect to a significance threshold of p 0.003 after Bonferroni correction for multiple testing (N = 16 SNP marker).
###end p 41
###begin title 42
CARD8
###end title 42
###begin p 43
###xml 25 31 25 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD8 </italic>
###xml 59 60 59 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 131 139 131 139 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic </sub>
###xml 148 156 148 156 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic </sub>
###xml 428 434 428 434 <sub xmlns:xlink="http://www.w3.org/1999/xlink">cases </sub>
###xml 448 457 448 457 <sub xmlns:xlink="http://www.w3.org/1999/xlink">controls </sub>
###xml 466 474 466 474 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic </sub>
###xml 587 588 587 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
In total, 13 SNPs in the CARD8 gene were genotyped (Figure 2). In our study, neither allele of rs2043211 was associated with CRC (Pallelic = 0.86 ORallelic = 1.01 (0.88-1.17). Variant rs11881179 (c.202A>G) is a coding SNP that leads to the substitution of valin by isoleucin at position 68 of the amino acid sequence. No difference in terms of the minor allele frequency (MAF) was observed between cases and controls (MAF:c.202Gcases = 0.1%, c.202Gcontrols = 0.1%, Pallelic = 0.965). The Caucasians allele frequencies in HAPMAP and the observed allele counts in our control group (Table 4) were very similar (p > 0.2), thereby justifying the use of HAPMAP for the selection of tagging SNPs. All remaining single point allelic and genotypic association tests resulted in nominal p-values between 0.09 and 0.99. Haplotype analysis yielded the lowest p value of 0.23 for a 3-locus haplotype spanning from rs10500300 to rs10405717.
###end p 43
###begin p 44
###xml 71 77 71 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD8 </italic>
Results of the genetic association analyses of the tagging SNPs in the CARD8 gene.
###end p 44
###begin p 45
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 136 138 136 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink"># </sup>
###xml 332 339 332 339 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic</sub>
###xml 356 361 356 361 <sub xmlns:xlink="http://www.w3.org/1999/xlink">HAP2 </sub>
###xml 365 370 365 370 <sub xmlns:xlink="http://www.w3.org/1999/xlink">HAP5 </sub>
###xml 446 451 446 451 <sub xmlns:xlink="http://www.w3.org/1999/xlink">HAP5 </sub>
a P value were not significant after Bonferroni correction for multiple testing, *no odds ratio calculated due to low allele frequency, # p-value is reported for the first marker in the haplotype window. The minor allele frequencies (MAF) for cases and controls are reported. P values and odds ratios are reported for the allelic (pallelic) test. Columns PHAP2 to PHAP5 refer to a sliding window haplotype analysis using COCAPHASE. For example, PHAP5 (0.417) for rs12984929 reports the global significance value for the window 5 haplotype spanning rs12984929-rs11672725- rs10500300- rs6509368- rs10405717.
###end p 45
###begin p 46
###xml 130 131 128 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 202 210 200 208 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic </sub>
###xml 221 229 219 227 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic </sub>
###xml 33 41 <span type="species:ncbi:9606">patients</span>
The subgroup analysis of younger patients (</=50 age at diagnosis) for rs2043211 yielded a similar allelic p-value of 0.23 (Table 4). The intronic SNP rs11670259 was significantly associated with CRC (Pallelic = 0.004, ORallelic = 1.46 (1.13-1.90), but remains only borderline significant in respect to a significance threshold of p 0.004 after Bonferroni correction for multiple testing (N = 13 SNP marker). None of the other single marker or haplotyp SNPs at that locus yielded significant p values after Bonferroni correction was applied.
###end p 46
###begin title 47
CARD15
###end title 47
###begin p 48
###xml 25 32 25 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 60 61 60 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 142 143 142 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 145 146 145 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
###xml 148 149 148 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T6">6</xref>
###xml 151 152 151 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T7">7</xref>
###xml 202 209 202 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 307 308 307 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
###xml 351 358 351 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 388 391 388 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
###xml 410 418 410 418 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic </sub>
###xml 427 437 427 437 <sub xmlns:xlink="http://www.w3.org/1999/xlink">genotypic </sub>
###xml 458 461 458 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
###xml 468 476 468 476 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic </sub>
###xml 485 495 485 495 <sub xmlns:xlink="http://www.w3.org/1999/xlink">genotypic </sub>
###xml 521 524 521 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
###xml 531 539 531 539 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic </sub>
###xml 548 558 548 558 <sub xmlns:xlink="http://www.w3.org/1999/xlink">genotypic </sub>
###xml 910 913 910 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
###xml 920 928 920 928 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic </sub>
###xml 937 947 937 947 <sub xmlns:xlink="http://www.w3.org/1999/xlink">genotypic </sub>
###xml 706 714 <span type="species:ncbi:9606">patients</span>
Eight SNP markers in the CARD15 gene were genotyped (Figure 3) and the results of the respective association analyses are summarised in Table 1, 5, 6 &7. The haplotype structure and the risk alleles at CARD15 are well defined [32], so that the initial analyses focussed on the three main coding SNPs (Table 5). No association was seen between CRC and CARD15 variants R702W (5.1% in cases vs 4.6% in controls; Pallelic = 0.50, Pgenotypic = 0.59), G908R (1.5% vs 1.2%; Pallelic = 0.43, Pgenotypic = 0.60) and L1007fs (3.6% vs 2.8%; Pallelic = 0.17, Pgenotypic = 0.36). Two compound heterozygotes carrying R702W and G908R and four compound heterozygotes carrying R702W and L1007fs were observed among the CRC patients, whereas non of these combinations was found in controls. The combined frequency of genotypes harbouring R702W, G908R or L1007fs was also not significantly different in cases and controls (10.2% vs 8.6%; Pallelic = 0.10, Pgenotypic = 0.10).
###end p 48
###begin p 49
###xml 71 78 71 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
Results of the genetic association analyses of the tagging SNPs in the CARD15 gene.
###end p 49
###begin p 50
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 136 138 136 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink"># </sup>
###xml 329 336 329 336 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic</sub>
###xml 353 358 353 358 <sub xmlns:xlink="http://www.w3.org/1999/xlink">HAP2 </sub>
###xml 362 367 362 367 <sub xmlns:xlink="http://www.w3.org/1999/xlink">HAP5 </sub>
###xml 443 448 443 448 <sub xmlns:xlink="http://www.w3.org/1999/xlink">HAP2 </sub>
a P value were not significant after Bonferroni correction for multiple testing, *no odds ratio calculated due to low allele frequency, # p-value reported for the first marker in the haplotype window. The minor allele frequencies (MAF) for cases and controls are reported. P values and odds ratios are reported for the allelic (pallelic) test. Columns PHAP2 to PHAP5 refer to a sliding window haplotype analysis using COCAPHASE. For example, PHAP2 (0.295) for rs2066847 reports the global significance value for the window 2 haplotype sapnning rs2066847- rs8056611.
###end p 50
###begin p 51
###xml 36 43 36 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 70 78 <span type="species:ncbi:9606">patients</span>
Genotype and allele frequencies for CARD15 mutations among German CRC patients and controls.
###end p 51
###begin p 52
###xml 67 71 67 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 137 145 137 145 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic </sub>
###xml 150 155 150 155 <sub xmlns:xlink="http://www.w3.org/1999/xlink">geno </sub>
###xml 214 216 214 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 217 222 217 222 <sub xmlns:xlink="http://www.w3.org/1999/xlink">geno </sub>
###xml 256 259 256 259 <sub xmlns:xlink="http://www.w3.org/1999/xlink">CAR</sub>
###xml 264 306 264 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">odds ratio for carriership of rare allele </italic>
###xml 312 315 312 315 <sub xmlns:xlink="http://www.w3.org/1999/xlink">REC</sub>
###xml 320 397 320 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">odds ratio for homozygosity of rare allele under the ressesive disease model </italic>
###xml 483 491 483 491 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic </sub>
###xml 496 501 496 501 <sub xmlns:xlink="http://www.w3.org/1999/xlink">geno </sub>
###xml 561 562 561 562 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
1*1 homozygous wild-type, 1*2 heterozygous, 2*2 homozygous mutant, (c) homozygous for mutant allele and compound heterozygous combined; Pallelic and Pgeno are calculated from the observed genotypes (1*1, 1*2, 2*2);a Pgeno 2*2 (c): genotypic p values and ORCAR(c): odds ratio for carriership of rare allele and ORREC(c): odds ratio for homozygosity of rare allele under the ressesive disease model were calculated by judging compound heterozygotes as homozygotes of the rare allele, Pallelic and Pgeno were calculated without considering compound heterozygotes; bP values and odds ratios for young CRC (</=45 age at diagnosis) were calculated against the total control cohort.
###end p 52
###begin p 53
Results of the genetic association analyses for subgroups stratified by disease presentation and family history of disease.
###end p 53
###begin p 54
###xml 36 43 36 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 234 235 234 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
Although the haplotype structure of CARD15 has been explored before, we performed a sliding window haplotype analysis of this locus for the sake of consistency. The results reflected the pattern seen in the coding SNP analysis (Table 5) and were essentially negative: Only a nominal significance level of 0.04 was obtained for the 2-locus haplotype spanning rs5743291 and rs2066847. None of the neighbouring haplotypes showed any evidence for an association with CRC.
###end p 54
###begin p 55
###xml 92 99 92 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 141 144 141 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
###xml 163 171 163 171 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic </sub>
###xml 181 191 181 191 <sub xmlns:xlink="http://www.w3.org/1999/xlink">genotypic </sub>
###xml 202 210 202 210 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic </sub>
###xml 232 243 232 243 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ressessive </sub>
###xml 395 398 393 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
###xml 417 425 415 423 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic </sub>
###xml 435 445 433 443 <sub xmlns:xlink="http://www.w3.org/1999/xlink">genotypic </sub>
###xml 457 465 455 463 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic </sub>
###xml 487 498 485 496 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ressessive </sub>
###xml 28 35 <span type="species:ncbi:9606">patient</span>
###xml 332 340 <span type="species:ncbi:9606">patients</span>
The analysis of the younger patient groups in contrast yielded a significant association of CARD15 R702W (rs2066844) with CRC (7.7% in cases vs 4.6% in controls; Pallelic = 0.029, Pgenotypic = 0.033, ORallelic = 1.75 (1.05-2.91), ORressessive = 9.46 (0.85-105.2). The association was even more pronounced when the most youngest CRC patients (</=45 age at diagnosis) were analysed (9.7% in cases vs 4.6% in controls; Pallelic = 0.008, Pgenotypic = 0.0008, ORallelic = 2.22 (1.21-4.05), ORressessive = 21.9 (1.96-245.4). The p value yielded for the genotypic association remains significant after Bonferroni correction. G908R and L1007fs were not found to be significantly associated with CRC in any of the analysed age groups.
###end p 55
###begin p 56
###xml 198 201 196 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
###xml 220 228 218 226 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic </sub>
###xml 239 249 237 247 <sub xmlns:xlink="http://www.w3.org/1999/xlink">genotypic </sub>
###xml 261 272 259 270 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ressessive </sub>
###xml 464 474 462 472 <sub xmlns:xlink="http://www.w3.org/1999/xlink">genotypic </sub>
###xml 488 500 486 498 <sub xmlns:xlink="http://www.w3.org/1999/xlink">carriership </sub>
###xml 522 533 520 531 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ressessive </sub>
###xml 648 658 646 656 <sub xmlns:xlink="http://www.w3.org/1999/xlink">genotypic </sub>
###xml 670 682 668 680 <sub xmlns:xlink="http://www.w3.org/1999/xlink">carriership </sub>
###xml 704 715 702 713 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ressessive </sub>
###xml 756 757 754 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T6">6</xref>
###xml 100 107 <span type="species:ncbi:9606">patient</span>
###xml 143 150 <span type="species:ncbi:9606">patient</span>
The combined frequency of genotypes harbouring R702W, G908R or L1007fs were significantly higher in patient than controls for the youngest CRC patient group (</=45 age at diagnosis) (16.7% in cases vs 8.6% in controls; Pallelic = 0.0014, Pgenotypic = 0.0021, ORressessive = 12.1 (2.37-61.36), both p-values remained significant after Bonferroni correction. When compound heterozygotes were classified as being equal to homozygotes of the mutant allele for R702W (Pgenotypic = 0.000013, ORcarriership = 1.99 (1.02-3.89), ORressessive = 32.9 (3.36-321.2) was yielded and for combined frequency of genotypes harbouring R702W, G908R or L1007fs R702W (Pgenotypic = 0.0001, ORcarriership = 2.19 (1.28-3.75), ORressessive = 12.1 (2.37-61.31), respectively (Table 6).
###end p 56
###begin p 57
###xml 119 122 119 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
###xml 141 149 141 149 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic </sub>
###xml 164 165 164 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 303 306 303 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
###xml 325 333 325 333 <sub xmlns:xlink="http://www.w3.org/1999/xlink">allelic </sub>
###xml 57 64 <span type="species:ncbi:9606">patient</span>
###xml 222 230 <span type="species:ncbi:9606">patients</span>
In contrast, R702W was not significant in the more older patient group (N = 901, >50 age at diagnosis), (4.7% in cases vs 4.6% in controls; Pallelic = 0.83) (Table 1). Similar negative results for R702W were obtained when patients diagnosed with CRC before age 60 (N = 597) were analysed (5.4% in cases vs 4.6% in controls; Pallelic = 0.3).
###end p 57
###begin title 58
Stratification analysis of disease presentation and family history
###end title 58
###begin p 59
###xml 30 39 30 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD4, 8 </italic>
###xml 43 46 43 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">15 </italic>
###xml 103 104 103 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T7">7</xref>
###xml 223 224 223 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T7">7</xref>
###xml 198 205 <span type="species:ncbi:9606">patient</span>
None of the analysed SNPs for CARD4, 8 and 15 was significantly associated (all p values > 0.05; Table 7) with tumour location or yielded significant association in the familial or non-familial CRC patient subgroups (Table 7 only lists a small selection of the analysed SNPs).
###end p 59
###begin title 60
Discussion
###end title 60
###begin p 61
###xml 676 695 676 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Helicobacter pylori</italic>
###xml 798 799 798 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 800 802 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 803 805 803 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 917 924 917 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 987 993 987 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD4 </italic>
###xml 997 1003 997 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD8 </italic>
###xml 676 695 <span type="species:ncbi:210">Helicobacter pylori</span>
The functional relationship between inflammation and cancer is well established and dates back to Virchow in 1863. He propagated this interesting hypothesis based on the observation that some classes of irritants, together with the tissue injury and causative inflammation, enhance cell proliferation. By now it is known that many cancers arise from sites of infection, chronic irritation and inflammation. About 15% of the global cancer burden is attributable to infectious agents, and inflammation is a major element of these chronic infections. For example, the development of mucosal associated lymphoid tissue (MALT) B cell lymphoma and gastric cancer is associated with Helicobacter pylori-induced chronic gastritis, and an increased risk of CRC accompanies inflammatory bowel disease (IBD) [4,33-35]. Therefore, we tried to replicate previously reported associations of functional SNPs in innate immunity gene CARD15 with CRC susceptibility, and also investigated variants of the CARD4 and CARD8 innate immune genes in this context.
###end p 61
###begin p 62
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 473 475 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 702 704 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 705 707 705 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 953 954 953 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 956 957 956 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 962 963 962 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
###xml 1031 1033 1031 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
The international HAPMAP project  has generated a whealth of genotype and marker information that significantly facilitates the design of candidate gene studies [25]. For our candidate gene study, a primary haplotype tagging approach was chosen, i.e. the genetic variation at both loci was captured by a set of carefully selected SNPs. This tagging approach is able to detect signals from hitherto unknown regulatory or functional elements in a given genetic region [28,36,37]. Therefore, it offers potential advantages over a direct mutation screen of the coding region of a gene because disease susceptibility may also be conferred by variations, for instance, in splice sites or intronic enhancers [38,39]. Tagging SNPs were thus selected from the public HAPMAP  resources. The genotype and allele frequencies for the SNPs investigated in our control population were not significantly different from those of the Caucasian HAPMAP individuals (Tables 3, 4 and 5), thereby justifying the selection of tag SNPs from this resource [25].
###end p 62
###begin p 63
###xml 121 128 121 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 673 675 673 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 700 702 700 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 869 871 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 22 30 <span type="species:ncbi:9606">patients</span>
###xml 948 956 <span type="species:ncbi:9606">patients</span>
We utilized over 1000 patients who have been operated for CRC, which renders our study the largest case-control study of CARD15 mutations reported so far. In Germany, the population median age of affection by CRC is about 69 years for males and 74 years for females [40]. The actual median age of onset in our cases was 59 years. In an additional attempt to increase the power of our investigations, only IBD-negative and cancer-free control individuals with a moderately higher median age of 68 years were used. Many polygenic disorders are characterized by a strong correlation between the age of onset of relatives, as has been documented for instance in breast cancer [41] and Alzheimer disease [42]. It is indeed plausible that the genetic influence upon the development of these disorders is partly reflected by the age at which individuals develop the disorder [43]. Confounding by population affiliation was minimized by the restriction to patients of German ancestry as determined by the birth place of both parents.
###end p 63
###begin p 64
###xml 138 139 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
The sample size used in this study has a power >80% for the detection of allelic odds ratios >1.5 at a significance level of 0.05 (Figure 4). For more frequent mutation variants, even odds ratios as small as 1.3 would have been detected with the same power.
###end p 64
###begin p 65
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 319 326 319 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 118 126 <span type="species:ncbi:9606">patients</span>
This notwithstanding, none of the single point nominal p values in any of the tests in the total cohort (N = 1044 CRC patients) were found to be <0.05. Thus, in contrast to Kurzawski et al. (2004) [15], Papaconstantinou et al. (2005) [16] and Roberts et al. (2006) [17], we found no evidence for an association between CARD15 variants and CRC susceptibility based on the findings of the total cohort.
###end p 65
###begin p 66
###xml 442 444 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 445 447 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 507 514 501 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 635 640 629 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G908R</italic>
###xml 836 843 830 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 945 952 939 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 1192 1194 1186 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1195 1197 1189 1191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 12 19 <span type="species:ncbi:9606">patient</span>
###xml 329 337 <span type="species:ncbi:9606">patients</span>
###xml 549 557 <span type="species:ncbi:9606">patients</span>
###xml 820 828 <span type="species:ncbi:9606">patients</span>
However, in patient subgroups of early disease manifestation (</=45 and </=50 age at diagnosis) we detected a significant association of the R702W mutation with CRC. In the German cohort, this association would have remained undiscovered if the subgroup analyses for earlier disease manifestation would had been confined only to patients with </=60 years at diagnosis, as done in previous studies that did not detect an association with CRC [18-20]. In line with this, the association signal for all tested CARD15 mutations totally fainted when CRC patients older than 50 years at diagnosis were analysed. No association was found for G908R. We observed an increase in the frequency of R702W and also 3020insC risk alleles and compound heterozygotes between both with decreasing age of diagnosis in non-IBD affected CRC patients. Thus, CARD15 mediated CRC disease susceptibility seems to be confined to early onset CRC in the German population. CARD15 R702W and 3020insC affect the C-terminal LRR-part of NOD2 lead to a reduced responsiveness to bacterial components and are assumed to influence the crosstalk with Toll-like receptor function that results in a proinflammatory cytokine bias [44-46]. The resulting chronic imflammatory state of the colon could provide the mechanistic link to cancer development.
###end p 66
###begin p 67
###xml 114 121 114 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 384 391 <span type="species:ncbi:9606">patient</span>
In the whole, however, our findings corroborate the two studies from Finnland and Hungary. Both studies disproved CARD15 mutations as major contributors to general 'sporadic' colorectal cancer disease susceptibility. In addition, none of the analysed SNPs was significantly associated with either tumour location or yielded significant association in the familial or non-familial CRC patient subgroups.
###end p 67
###begin p 68
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD4 </italic>
###xml 75 81 75 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD8 </italic>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 299 305 299 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD4 </italic>
###xml 463 469 463 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD4 </italic>
###xml 621 623 621 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 963 965 961 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 429 437 <span type="species:ncbi:9606">patients</span>
###xml 594 602 <span type="species:ncbi:9606">patients</span>
###xml 932 940 <span type="species:ncbi:9606">patients</span>
Furthermore, our study did not unravel any major contribution of CARD4 and CARD8 variants to the predisposition to CRC despite the results of recent genome-wide association studies [47-54] showing that part of the CRC risk is due to common low-risk variants. The intronic complex indel polymorphism CARD4 ND1+ 32656 was not significantly disease associated neither in the total cohort nor in the subgroup analysis of younger CRC patients. The coding polymorphism CARD4 E266K was reported to be associated with Crohn's disease in Hungarian population with the risk allele being more frequent in patients than in controls [31]. In contrast, we observed the E266K mutant allele 8% less frequently in the younger subgroup of CRC cases (</=50 age at diagnosis) compared to controls. Interestingly, in a Scottish IBD population the mutant allele was likewise observed less frequently, though not significant, in early onset IBD (<17 age) patients compared to controls [55].
###end p 68
###begin p 69
###xml 346 353 346 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 387 389 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
There may be many explanations of the lack of significant results for the total CRC cohort in the present study. A major reason might be population genetic differences in terms of allele frequencies and in terms of the contribution of individual risk variants. Regional heterogeneity within Europe as reported with respect to the contribution of CARD15 variants to CD susceptibility [32,55] may also apply to the CRC risk. In addition, environmental factors may differ widely even between Caucasian populations.
###end p 69
###begin p 70
###xml 214 221 214 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 271 276 271 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 279 281 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 304 309 304 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 340 347 <span type="species:ncbi:9606">patient</span>
Another critical point may be the necessity of a sufficient sample size utilized in association studies. There might be a weakness in this promise of previously published data, as studies demonstrating evidence of CARD15 as a susceptibility gene for CRC, named Kurzawski et al. [15] and Papaconstantinou et al. [16], feature relatively low patient numbers.
###end p 70
###begin title 71
Conclusion
###end title 71
###begin p 72
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD4</italic>
###xml 67 73 67 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD8 </italic>
###xml 77 84 77 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 446 453 446 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD15 </italic>
###xml 590 596 590 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CARD4 </italic>
###xml 307 315 <span type="species:ncbi:9606">patients</span>
###xml 377 385 <span type="species:ncbi:9606">patients</span>
###xml 429 436 <span type="species:ncbi:9606">patient</span>
###xml 621 629 <span type="species:ncbi:9606">patients</span>
In conclusion, common variants of the innate immunity genes CARD4, CARD8 and CARD15 are not associated with susceptibility to CRC in German population. In accordance with previous studies, these findings suggest that such variants are unlikey to play a major role disease development in the majority of CRC patients. However, our findings suggest a different situation for CRC patients with early disease manifestation. For this patient subgroup CARD15 R702W was found to be significantly associated with disease susceptibility. Independent studies are also needed to examine the effect of CARD4 E266K in early onset CRC patients.
###end p 72
###begin title 73
Competing interests
###end title 73
###begin p 74
The authors declare that they have no competing interests.
###end p 74
###begin title 75
Authors' contributions
###end title 75
###begin p 76
###xml 56 64 <span type="species:ncbi:9606">patients</span>
###xml 242 249 <span type="species:ncbi:9606">patient</span>
NM, WS, BS, CR, PR, CR, recruited and characterized the patients. SB, OK, AF performed and supervised the data analysis. JE, PR, MB, HK, UF, CB, JT, SH participated in study design and the drafting of the manuscript. MK and SS structured the patient recruitment project. JH and CS conceived and coordinated the study and drafted the manuscript. All authors have read and approved the final manuscript.
###end p 76
###begin title 77
Pre-publication history
###end title 77
###begin p 78
The pre-publication history for this paper can be accessed here:
###end p 78
###begin p 79

###end p 79
###begin title 80
Acknowledgements
###end title 80
###begin p 81
###xml 23 31 <span type="species:ncbi:9606">patients</span>
The cooperation of all patients, their families and physicians is gratefully acknowledged. Especially thanks are due to Huberta von Eberstein and her team (POPGEN Biobank project), and to the heads of the surgical departments involved: Ilka Vogel (Stadtisches Krankenhaus Kiel), Hermann Dittrich (Rendsburg), Jurgen Belz (Husum), Rainer Quaschling (Eckernforde), Hodjat Shekarriz (Schleswig), Volker Mendel (Flensburg), Werner Neugebauer (Flensburg), Friedrich Kallinowski (Heide), Anton Schafmayer (Luneburg), Sebastian Debus (Hamburg Harburg), Jiri Klima (Niebull), Wolfgang Teichmann (Hamburg Altona), Lutz Steinmuller (Hamburg Eilbek), Marco Sailer (Hamburg Bergedorf), Ulrich Mullerleile (Hamburg Barmbek), Benno Stinner (Stade), Hans Fred Weiser (Rotenburg), Heiner Wenk (Bremen), Eick Hartwig Egberts (Detmold), Guido Schurrmann (Itzehoe), Albrecht Eggert (Reinbek), Nikolas Schwarz (Neumunster), Gunter Froschle (Bad Oldesloh) and Hendrik Schimmelpenning (Neustadt).
###end p 81
###begin article-title 82
Familial risk for colorectal cancers are mainly due to heritable causes
###end article-title 82
###begin article-title 83
Familial relative risk of colorectal cancer: a population-based study
###end article-title 83
###begin article-title 84
Colorectal cancer mortality in first-degree relatives of early-onset colorectal cancer cases
###end article-title 84
###begin article-title 85
Inflammation and cancer: back to Virchow?
###end article-title 85
###begin article-title 86
Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease
###end article-title 86
###begin article-title 87
Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared
###end article-title 87
###begin article-title 88
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
###end article-title 88
###begin article-title 89
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
###end article-title 89
###begin article-title 90
Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations
###end article-title 90
###begin article-title 91
The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease
###end article-title 91
###begin article-title 92
CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure
###end article-title 92
###begin article-title 93
The NOD: a signaling module that regulates apoptosis and host defense against pathogens
###end article-title 93
###begin article-title 94
Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease
###end article-title 94
###begin article-title 95
TUCAN (CARD8) Genetic Variants and Inflammatory Bowel Disease
###end article-title 95
###begin article-title 96
The NOD2 3020insC mutation and the risk of colorectal cancer
###end article-title 96
###begin article-title 97
Association between mutations in the CARD15/NOD2 gene and colorectal cancer in a Greek population
###end article-title 97
###begin article-title 98
###xml 62 70 <span type="species:ncbi:9606">patients</span>
Caspase recruitment domain-containing protein 15 mutations in patients with colorectal cancer
###end article-title 98
###begin article-title 99
NOD2 3020insC alone is not sufficient for colorectal cancer predisposition
###end article-title 99
###begin article-title 100
No evidence for association of NOD2 R702W and G908R with colorectal cancer
###end article-title 100
###begin article-title 101
###xml 151 159 <span type="species:ncbi:9606">patients</span>
Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients
###end article-title 101
###begin article-title 102
###xml 40 48 <span type="species:ncbi:9606">patients</span>
PopGen: Population-based recruitment of patients and controls for the analysis of complex genotype-phenotype relationships
###end article-title 102
###begin article-title 103
A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines
###end article-title 103
###begin article-title 104
An integrated system for high throughput TaqMan based SNP genotyping
###end article-title 104
###begin article-title 105
Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study
###end article-title 105
###begin article-title 106
###xml 23 28 <span type="species:ncbi:9606">human</span>
A haplotype map of the human genome
###end article-title 106
###begin article-title 107
Pedigree disequilibrium tests for multilocus haplotypes
###end article-title 107
###begin article-title 108
PS power and sample size program available for free on the Internet
###end article-title 108
###begin article-title 109
Efficiency and power in genetic association studies
###end article-title 109
###begin article-title 110
Haploview: analysis and visualization of LD and haplotype maps
###end article-title 110
###begin article-title 111
No association between the functional CARD4 insertion/deletion polymorphism and inflammatory bowel diseases in the German population
###end article-title 111
###begin article-title 112
###xml 130 138 <span type="species:ncbi:9606">patients</span>
NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease
###end article-title 112
###begin article-title 113
Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations
###end article-title 113
###begin article-title 114
Inflammation and cancer
###end article-title 114
###begin article-title 115
Chronic inflammation and cancer
###end article-title 115
###begin article-title 116
Innate immunity in inflammatory bowel disease
###end article-title 116
###begin article-title 117
Efficiency and consistency of haplotype tagging of dense SNP maps in multiple samples
###end article-title 117
###begin article-title 118
Genome-wide association studies for common diseases and complex traits
###end article-title 118
###begin article-title 119
A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis
###end article-title 119
###begin article-title 120
An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis
###end article-title 120
###begin article-title 121
Krebs in Deutschland 2003-2004. Haufigkeiten und Trends
###end article-title 121
###begin article-title 122
Age at onset as an indicator of familial risk of breast cancer
###end article-title 122
###begin article-title 123
Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia
###end article-title 123
###begin article-title 124
Random-effects Cox proportional hazards model: general variance components methods for time-to-event data
###end article-title 124
###begin article-title 125
Investigation of NOD1/CARD4 variation in inflammatory bowel disease using a haplotype-tagging strategy
###end article-title 125
###begin article-title 126
Crohn's Disease-Associated NOD2 Variants Share a Signaling Defect in Response to Lipopolysaccharide and Peptidoglycan
###end article-title 126
###begin article-title 127
###xml 23 28 <span type="species:ncbi:9606">human</span>
NOD-like receptors and human diseases
###end article-title 127
###begin article-title 128
A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21
###end article-title 128
###begin article-title 129
Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24
###end article-title 129
###begin article-title 130
A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3
###end article-title 130
###begin article-title 131
Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21
###end article-title 131
###begin article-title 132
A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk
###end article-title 132
###begin article-title 133
Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer
###end article-title 133
###begin article-title 134
Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk
###end article-title 134
###begin article-title 135
Investigation of the colorectal cancer susceptibility region on chromosome 8q24.21 in a large German case-control sample
###end article-title 135
###begin article-title 136
###xml 75 83 <span type="species:ncbi:9606">patients</span>
NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe?
###end article-title 136

